| HOME >> BIOLOGY >> TECHNOLOGY |
VIRGINIA BEACH, Va., Nov. 28 /PRNewswire-USNewswire/ -- LifeNet Health, a leading biomedical and allograft agency, announces a strategic partnership with IMS (Integrated Medical Systems International, Inc.), the InstrumentReady(TM) company, to create new software tools for LifeNet Health customers, improving the tracking of allograft bio-implants.
The agreement calls for the development, marketing, distribution, and support of a LifeNet Health vendor version of IMS' tissue tracking software. The new software will help LifeNet Health customers better track their tissues and inventory and create a stream-lined system that provides life-enhancing tissue grafts to hospitals in a timely process. The system will track tissue implants throughout hospital locations specified by the user, and the technology will manage and control inventory for them. This specific system, designed to meet the needs of LifeNet Health's customers, will help ensure safety and meet current regulations.
"This is an exciting opportunity for us to offer a new system to our customers. Our top priority is the safety of our tissue grafts. The new software and distribution tools by IMS help guarantee that commitment to the patients. IMS is a leader in healthcare solutions, and we are proud to enter into this alliance with them," stated Doug Wilson, LifeNet Health Executive Vice President.
Gene Robinson, President and CEO of IMS, added, "We are honored to begin work with LifeNet Health. Both organizations recognize the critical nature of the mission to help medical teams save lives and restore health around the world. This strategic partnership will offer LifeNet Health customers the software technology to enhance their processes, providing additional ways to protect and manage the precious gift of donated tissue."
Over 2,000 healthcare facilities throughout the United States have
partnered with IMS (Integrated Medical Systems International, Inc.), the
Instrume
'/>"/>
| SOURCE LifeNet Health Copyright©2007 PR Newswire. All rights reserved |